154 related articles for article (PubMed ID: 23524636)
1. No changes in striatal dopamine transporter in antidepressant-treated patients with major depression.
Wu CK; Chin Chen K; See Chen P; Chiu NT; Yeh TL; Lee IH; Yang YK
Int Clin Psychopharmacol; 2013 May; 28(3):141-4. PubMed ID: 23524636
[TBL] [Abstract][Full Text] [Related]
2. SPECT imaging of dopamine transporters with (99m)Tc-TRODAT-1 in major depression and Parkinson's disease.
Wu H; Lou C; Huang Z; Shi G
J Neuropsychiatry Clin Neurosci; 2011; 23(1):63-7. PubMed ID: 21304140
[TBL] [Abstract][Full Text] [Related]
3. Greater striatal dopamine transporter density may be associated with major depressive episode.
Amsterdam JD; Newberg AB; Soeller I; Shults J
J Affect Disord; 2012 Dec; 141(2-3):425-31. PubMed ID: 22482744
[TBL] [Abstract][Full Text] [Related]
4. Higher striatal dopamine transporters in euthymic patients with bipolar disorder: a SPECT study with [Tc] TRODAT-1.
Chang TT; Yeh TL; Chiu NT; Chen PS; Huang HY; Yang YK; Lee IH; Lu RB
Bipolar Disord; 2010 Feb; 12(1):102-6. PubMed ID: 20148872
[TBL] [Abstract][Full Text] [Related]
5. Distribution volume ratio of serotonin and dopamine transporters in euthymic patients with a history of major depression - a dual-isotope SPECT study.
Hsieh PC; Lee IH; Yeh TL; Chen KC; Huang HC; Chen PS; Yang YK; Yao WJ; Lu RB; Chiu NT
Psychiatry Res; 2010 Dec; 184(3):157-61. PubMed ID: 21030217
[TBL] [Abstract][Full Text] [Related]
6. The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1.
Schmitt GJ; Meisenzahl EM; Frodl T; La Fougère C; Hahn K; Möller HJ; Dresel S
J Psychopharmacol; 2005 Sep; 19(5):488-93. PubMed ID: 16166186
[TBL] [Abstract][Full Text] [Related]
7. [Change of dopamine transporter activity (DAT) during the action of bupropion (in depression)].
Szabó Z; Argyelán M; Kanyó B; Pávics L; Janka Z
Neuropsychopharmacol Hung; 2004 Jun; 6(2):79-81. PubMed ID: 15787205
[TBL] [Abstract][Full Text] [Related]
8. The relationship between the striatal dopamine transporter and novelty seeking and cognitive flexibility in opioid dependence.
Liang CS; Ho PS; Yen CH; Chen CY; Kuo SC; Huang CC; Yeh YW; Ma KH; Huang SY
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Mar; 74():36-42. PubMed ID: 27940252
[TBL] [Abstract][Full Text] [Related]
9. Decreased dopamine transporter availability in male smokers -- a dual isotope SPECT study.
Yang YK; Yao WJ; Yeh TL; Lee IH; Chen PS; Lu RB; Chiu NT
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):274-9. PubMed ID: 17900774
[TBL] [Abstract][Full Text] [Related]
10. Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.
Brunswick DJ; Amsterdam JD; Mozley PD; Newberg A
Am J Psychiatry; 2003 Oct; 160(10):1836-41. PubMed ID: 14514499
[TBL] [Abstract][Full Text] [Related]
11. Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers--a SPECT study.
Chen PS; Yeh TL; Lee IH; Lin CB; Tsai HC; Chen KC; Chiu NT; Yao WJ; Yang YK; Chou YH
Neuroimage; 2011 Jun; 56(3):1526-30. PubMed ID: 21371559
[TBL] [Abstract][Full Text] [Related]
12. Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients.
Zaaijer ER; van Dijk L; de Bruin K; Goudriaan AE; Lammers LA; Koeter MW; van den Brink W; Booij J
Psychopharmacology (Berl); 2015 Jul; 232(14):2597-607. PubMed ID: 25757673
[TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients.
Schmitt GJ; Frodl T; Dresel S; la Fougère C; Bottlender R; Koutsouleris N; Hahn K; Möller HJ; Meisenzahl EM
Eur Arch Psychiatry Clin Neurosci; 2006 Mar; 256(2):115-21. PubMed ID: 16284713
[TBL] [Abstract][Full Text] [Related]
14. Greater availability of dopamine transporters in patients with major depression--a dual-isotope SPECT study.
Yang YK; Yeh TL; Yao WJ; Lee IH; Chen PS; Chiu NT; Lu RB
Psychiatry Res; 2008 Apr; 162(3):230-5. PubMed ID: 18295460
[TBL] [Abstract][Full Text] [Related]
15. Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
Yeh YW; Ho PS; Kuo SC; Chen CY; Liang CS; Yen CH; Huang CC; Ma KH; Shiue CY; Huang WS; Shyu JF; Wan FJ; Lu RB; Huang SY
Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu120. PubMed ID: 25568284
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter density may be associated with the depressed affect in healthy subjects.
Newberg A; Amsterdam J; Shults J
Nucl Med Commun; 2007 Jan; 28(1):3-6. PubMed ID: 17159542
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study.
Argyelán M; Szabó Z; Kanyó B; Tanács A; Kovács Z; Janka Z; Pávics L
J Affect Disord; 2005 Dec; 89(1-3):115-23. PubMed ID: 16213028
[TBL] [Abstract][Full Text] [Related]
18. Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study.
Rominger A; Cumming P; Brendel M; Xiong G; Zach C; Karch S; Tatsch K; Bartenstein P; la Fougère C; Koch W; Pogarell O
Eur Neuropsychopharmacol; 2015 Jun; 25(6):873-81. PubMed ID: 25819144
[TBL] [Abstract][Full Text] [Related]
19. Lower availability of midbrain serotonin transporter between healthy subjects with and without a family history of major depressive disorder - a preliminary two-ligand SPECT study.
Hsieh PC; Chen KC; Yeh TL; Lee IH; Chen PS; Yao WJ; Chiu NT; Chen CC; Liao MH; Yang YK
Eur Psychiatry; 2014 Sep; 29(7):414-8. PubMed ID: 24439516
[TBL] [Abstract][Full Text] [Related]
20. Lower availability of striatal dopamine transporter in generalized anxiety disorder: a preliminary two-ligand SPECT study.
Lee LT; Tsai HC; Chi MH; Chang WH; Chen KC; Lee IH; Chen PS; Yao WJ; Chiu NT; Yang YK
Int Clin Psychopharmacol; 2015 May; 30(3):175-8. PubMed ID: 25647452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
